NLS Pharmaceutics Debt to Equity Ratio Analysis

NLS Pharmaceutics Ltd (NLSP)

3.365 +0.08 (+2.28%) USD | NASDAQ | Nov 21, 16:00

3.17 -0.20 (-5.79%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.

Date	Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

AC Immune SA	0.00
CRISPR Therapeutics AG	--
Addex Therapeutics Ltd	0.00
Molecular Partners AG	0.00
MoonLake Immunotherapeutics	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	1.194M
Total Liabilities (Quarterly)	10.46M
Shareholders Equity (Quarterly)	-9.268M